PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 78.37 USD 0.86% Market Closed
Market Cap: 6.3B USD

Intrinsic Value

The intrinsic value of one PTCT stock under the Base Case scenario is 62.38 USD. Compared to the current market price of 78.37 USD, PTC Therapeutics Inc is Overvalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PTCT Intrinsic Value
62.38 USD
Overvaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
PTC Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about PTCT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PTCT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PTC Therapeutics Inc.

Explain Valuation
Compare PTCT to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PTCT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PTC Therapeutics Inc

Current Assets 2B
Cash & Short-Term Investments 1.7B
Receivables 203.1m
Other Current Assets 116.9m
Non-Current Assets 635.9m
PP&E 137.7m
Intangibles 478.8m
Other Non-Current Assets 19.4m
Current Liabilities 866.2m
Accounts Payable 91.9m
Accrued Liabilities 98.6m
Other Current Liabilities 675.7m
Non-Current Liabilities 1.9B
Long-Term Debt 1.8B
Other Non-Current Liabilities 98.1m
Efficiency

Free Cash Flow Analysis
PTC Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PTC Therapeutics Inc

Revenue
1.8B USD
Cost of Revenue
-56.3m USD
Gross Profit
1.7B USD
Operating Expenses
-789.6m USD
Operating Income
933.2m USD
Other Expenses
-181.5m USD
Net Income
751.7m USD
Fundamental Scores

PTCT Profitability Score
Profitability Due Diligence

PTC Therapeutics Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional Operating Margin
ROIC is Increasing
63/100
Profitability
Score

PTC Therapeutics Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

PTCT Solvency Score
Solvency Due Diligence

PTC Therapeutics Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Short-Term Solvency
Positive Net Debt
67/100
Solvency
Score

PTC Therapeutics Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PTCT Price Targets Summary
PTC Therapeutics Inc

Wall Street analysts forecast PTCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PTCT is 83.37 USD with a low forecast of 55.55 USD and a high forecast of 123.9 USD.

Lowest
Price Target
55.55 USD
29% Downside
Average
Price Target
83.37 USD
6% Upside
Highest
Price Target
123.9 USD
58% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

PTC Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PTCT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PTCT Insider Trading
Buy and sell transactions by insiders

PTCT News

Other Videos
What is the Intrinsic Value of one PTCT stock?

The intrinsic value of one PTCT stock under the Base Case scenario is 62.38 USD.

Is PTCT stock undervalued or overvalued?

Compared to the current market price of 78.37 USD, PTC Therapeutics Inc is Overvalued by 20%.

Back to Top